IL-1ra Antibody (6A8): sc-101616
- IL-1ra Antibody (6A8) is a mouse monoclonal IgG1 provided at 200 µg/ml
- raised against recombinant IL-1ra of human origin
- recommended for detection of IL-1ra of human origin by WB, IP and ELISA; non cross-reactive with IL-1α or IL-1β
- At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for IL-1ra Antibody (6A8). This work is in progress.
IL-1ra Antibody (6A8) is a mouse monoclonal IgG1 antibody that detects interleukin-1 receptor antagonist (IL-1ra) in human samples through applications such as western blotting (WB), immunoprecipitation (IP), and enzyme-linked immunosorbent assay (ELISA). IL-1ra plays a crucial role in modulating the immune response by inhibiting the activity of interleukin-1α and interleukin-1β, both of which are key pro-inflammatory cytokines. By binding to the same receptors as IL-1α and IL-1β without eliciting a biological response, IL-1ra effectively acts as a natural antagonist, thereby preventing excessive inflammation and tissue damage. This regulatory function is particularly important in conditions such as rheumatoid arthritis, where the overactivity of IL-1 can lead to severe joint inflammation and degradation. The presence of four isoforms of IL-1ra, produced through alternative splicing, adds complexity to regulatory mechanisms and potential therapeutic applications. Anti-IL-1ra antibody (6A8) serves as an essential tool for researchers studying the intricate balance of pro-inflammatory and anti-inflammatory signals in various physiological and pathological contexts.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
IL-1ra Antibody (6A8) References:
- The balance between IL-1 and IL-1Ra in disease. | Arend, WP. 2002. Cytokine Growth Factor Rev. 13: 323-40. PMID: 12220547
- From supernatants to cytokines: a personal view on the early history of IL-1, IL-1Ra, TNF and its inhibitor in rheumatology. | Dayer, JM. 2018. Arthritis Res Ther. 20: 101. PMID: 29848388
- IL-1RA suppresses esophageal cancer cell growth by blocking IL-1α. | Chen, S., et al. 2019. J Clin Lab Anal. 33: e22903. PMID: 31102307
- Bone Marrow-Derived IL-1Ra Increases TNF Levels Poststroke. | von Linstow, CU., et al. 2021. Cells. 10: PMID: 33924148
- IL-1Ra deficiency accelerates intervertebral disc degeneration in C57BL6J mice. | Swamy, G., et al. 2022. JOR Spine. 5: e1201. PMID: 35783913
- IL-1 receptor antagonist (IL-1RA) suppresses a hyper-IL-17 response-mediated bone loss in a murine experimental periodontitis. | Zhang, J., et al. 2022. Arch Oral Biol. 144: 105555. PMID: 36191445
- IL-1ra treatment prevents chronic social defeat stress-induced depression-like behaviors and glutamatergic dysfunction via the upregulation of CREB-BDNF. | Li, M., et al. 2023. J Affect Disord. 335: 358-370. PMID: 37217098
- Expression and characterization of recombinant IL-1Ra in Aspergillus oryzae as a system. | Mahmoudi Azar, L., et al. 2023. BMC Biotechnol. 23: 15. PMID: 37340430
- Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus. | Lindblom, J., et al. 2023. Front Immunol. 14: 1257085. PMID: 38098483
- Therapeutic Effects of IL-1RA against Acute Bacterial Infections, including Antibiotic-Resistant Strains. | Ambite, I., et al. 2023. Pathogens. 13: PMID: 38251349
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
IL-1ra Antibody (6A8) | sc-101616 | 200 µg/ml | $316.00 |